Custom Genetic Screening Market Expected to Hit USD 15.0 Billion by 2035 with a Remarkable 10.6% CAGR

WiseGuy Reports, Today, Feb 2026 (Press Release) – Global Industry Outlook on Custom Genetic Screening Market:

Custom Genetic Screening Market Growth Research Report and Trends Analysis By Test Type (Carrier Screening, Preconception Screening, Pharmacogenomics, Prenatal Screening, Neonatal Screening), By Technology (Next-Generation Sequencing (NGS), Microarrays, PCR-Based Technologies, Sanger Sequencing), By Application (Cancer Screening, Cardiovascular Disease Screening, Neurological Disorders Screening, Metabolic Disorders Screening, Infectious Diseases Screening), By Sample Type (Blood, Saliva, Amniotic Fluid, Chorionic Villi, Tissue Biopsy) and By Regions - Forecast to 2032

Custom Genetic Screening Market Technological advancements are playing a critical role in shaping the Custom Genetic Screening Market with manufacturers focusing on improved accuracy, efficiency, and patient-centric designs. In parallel, supportive regulatory frameworks, expanding healthcare infrastructure, and growing investments in R&D are further strengthening market growth. Emerging economies are also contributing significantly, supported by improving access to care and rising healthcare expenditure.

Ask for Sample Pages Here: https://www.wiseguyreports.com/sample-request?id=610012

Custom Genetic Screening Market Set to Reach USD 15 Billion by 2035: Market Forecast and Key Insights

The Custom Genetic Screening Market has emerged as a pivotal segment within the healthcare industry, driven by rising demand for personalized medicine and advancements in genomic technologies. Valued at USD 5.0 billion in 2024, the market is projected to reach USD 5.5 billion in 2025 and surge to USD 15.0 billion by 2035, registering a robust CAGR of 10.6% during the forecast period. This growth reflects heightened consumer awareness, increasing prevalence of genetic disorders, and growing government support and funding.

Market Size and Company Landscape

The market size of custom genetic screening continues to expand as leading companies focus on innovative solutions to address personalized healthcare needs. Key players in the market include Myriad Genetics, Abbott Laboratories, Roche Diagnostics, Natera, PerkinElmer, Guardant Health, Thermo Fisher Scientific, Fulgent Genetics, BGI Genomics, GeneDx, 23andMe, Illumina, Pacific Biosciences, Agilent Technologies, and d mg Lab. These market top companies are leveraging advanced technologies and strategic collaborations to strengthen their presence and capture a larger market share.

Segmental Analysis

The Custom Genetic Screening Market is segmented based on testing type, technology, application, end use, and region. Testing types include predictive testing, carrier testing, pharmacogenomic testing, and others, catering to diverse medical requirements. Technology segments cover next-generation sequencing, microarrays, PCR-based screening, and emerging CRISPR-based techniques, each offering unique advantages in accuracy and scalability. Applications span disease risk assessment, prenatal and neonatal screening, oncology, pharmacogenomics, and ancestry analysis. End users comprise hospitals, diagnostic laboratories, research institutes, and direct-to-consumer services, reflecting the market’s wide-reaching impact.

You Can Purchase Complete Report: https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=610012

Key Market Dynamics

The market dynamics of custom genetic screening are shaped by multiple factors. Rising demand for personalized medicine continues to drive market growth, as clinicians increasingly rely on genetic insights to tailor treatment plans. The increasing prevalence of genetic disorders is pushing healthcare providers and consumers toward regular genetic assessments. Technological advancements in genomic sequencing and data analytics are improving testing efficiency and reducing costs, which fuels market adoption. Additionally, growing awareness of genetic screening and proactive government initiatives with funding support further strengthen the market business insights for investors and stakeholders.

Regional Analysis

Regionally, North America dominates the Custom Genetic Screening Market, led by the US and Canada, owing to advanced healthcare infrastructure and high adoption of innovative diagnostic technologies. Europe follows closely, with Germany, the UK, and France driving the market due to robust research activities and supportive regulatory frameworks. In the APAC region, countries such as China, India, Japan, and South Korea are witnessing rapid growth, fueled by rising healthcare spending and awareness campaigns. South America and MEA regions, including Brazil, Mexico, GCC countries, and South Africa, are also experiencing significant expansion, highlighting emerging market opportunities in underserved areas.

Market Forecast and Projections

The market forecast for custom genetic screening indicates sustained market growth driven by rising consumer interest in ancestry and personalized health services. Expansion of home genetic testing services, along with advancements in CRISPR and precision medicine technologies, is expected to create new revenue streams. Market projections suggest that stakeholders can capitalize on these trends to enhance market share and secure a competitive edge. The market global outlook remains positive, with continued investment in R&D and strategic partnerships shaping future developments.

Key Highlights

• Market Size 2024: USD 5.0 Billion | Market Size 2035: USD 15.0 Billion
• CAGR (2025-2035): 10.6%
• Key Players: Myriad Genetics, Abbott Laboratories, Roche Diagnostics, Natera, PerkinElmer, Guardant Health, Thermo Fisher Scientific, Fulgent Genetics, BGI Genomics, GeneDx, 23andMe, Illumina, Pacific Biosciences, Agilent Technologies, d mg Lab
• Segments Covered: Testing Type, Technology, Application, End Use, Regional
• Regions Covered: North America, Europe, APAC, South America, MEA
• Market Opportunities: Personalized medicine, CRISPR advancements, home genetic testing, increasing awareness of genetic disorders

The Custom Genetic Screening Market continues to demonstrate impressive market growth dynamics, supported by technological innovations, regional expansion, and increasing consumer awareness. With strategic investments and continuous development, the market is poised to achieve significant milestones, redefining the future of personalized healthcare.

Global Funding Flows & Investment Patterns

Global digital health funding reached $28.8 billion in 2025, with the U.S. leading the sector, followed by Europe’s fast-growing funding rates and rising investment in Asia Pacific and the Middle East — though Africa saw declines in venture funding.

Healthcare policy and funding in 2026 reflect a blend of national budget expansions, multilateral partnerships, and regional innovation, shaped by both domestic needs and global health priorities. While developed economies like the U.S. and EU continue strategic health investments, Asia, Africa, and the Middle East are leveraging partnerships and creative financing to build resilient, equitable health systems.

Read More Details of Premium Research Report: https://www.wiseguyreports.com/reports/custom-genetic-screening-market

Custom Genetic Screening Market Strategic Themes for Healthcare Industry across the Globe

·        Universal Health Coverage (UHC)

·        Digital Health & Innovation

·        Health Workforce Investments

·        Sustainable Financing Models

·        Language Translated Reports

From a competitive perspective, key players are emphasizing product innovation, strategic partnerships, and geographic expansion to strengthen their market presence. Digital integration, automation, and personalized healthcare approaches are creating new opportunities, while value-based care models are influencing purchasing decisions across regions.

Health system transformation efforts that emphasize primary care accessibility, workforce expansion, and health digitalisation are being supported by funds from the World Bank’s Health System Transformation & Resilience Fund and co-financing with organizations such as Gavi and the Global Fund.

Global Language Translated Pages of Custom Genetic Screening Market - カスタム遺伝子スクリーニング市場規模 | Marktanteile für kundenspezifische genetische Screenings | Analyse du marché du dépistage génétique personnalisé | 맞춤형 유전자 검사 시장 분석 | 定制基因筛查市场概述 | Tendencias del mercado de cribado genético personalizado